Why Genetic Screening Matters in IVF: Protecting Future Generations from Inherited Diseases

In-vitro fertilization (IVF) has brought hope to millions of couples struggling with infertility. While the technology itself has advanced tremendously over the past few decades, an important development that often gets overlooked is the integration of genetic screening into IVF cycles. As more prospective parents explore IVF as a path to parenthood, understanding why genetic disease screening is recommended—and sometimes essential—is crucial.

What Is Genetic Screening in IVF?

Genetic screening in the context of IVF typically refers to two related but distinct processes:

1. Carrier Screening for Parents
   This test checks whether either parent is a carrier of certain inherited genetic conditions such as cystic fibrosis, Tay-Sachs disease, spinal muscular atrophy, thalassemia, and hundreds of others. Carriers often show no symptoms themselves but can pass the condition to their children if both partners carry the same mutation.

2. Embryonic Genetic Testing (PGT-M / PGT-A)
   Once embryos are created through IVF, a few cells can be biopsied from each embryo and tested in the lab for:

   • PGT-M (Preimplantation Genetic Testing for Monogenic disorders): This screens embryos for specific inherited diseases when the parents are known carriers.

   • PGT-A (Preimplantation Genetic Testing for Aneuploidy): This checks for chromosomal abnormalities like Down syndrome or Turner syndrome, although not directly linked to inherited genetic conditions.

Why Is Genetic Screening Recommended?

1. To Prevent Severe Genetic Disorders in Children

Many genetic disorders are life-threatening, cause significant disability, or result in shortened life expectancy. For example:

• Spinal Muscular Atrophy (SMA) is a leading genetic cause of infant death.

• Cystic Fibrosis (CF) can cause chronic lung disease and digestive issues.

• Thalassemia Major requires lifelong blood transfusions.

If both parents carry the same mutated gene, there’s a 25% chance that their child will inherit the disease. Identifying these risks before pregnancy allows parents to make informed reproductive choices.

2. To Increase IVF Success Rates

Genetic abnormalities are one of the main reasons why embryos fail to implant, miscarry, or result in birth defects. With PGT-A, embryos can be screened for chromosomal issues before transfer, increasing the chance of a healthy pregnancy and reducing the likelihood of miscarriage.

3. To Reduce Emotional and Financial Burden

IVF is physically, emotionally, and financially demanding. Discovering a genetic disease during a pregnancy (via amniocentesis or other prenatal tests) can lead to extremely difficult decisions. Preimplantation genetic screening allows parents to select healthy embryos and avoid the trauma of termination or the burden of raising a child with a severe condition.

Who Should Consider Genetic Screening?

While genetic screening is valuable for all IVF patients, it is particularly important for:

• Couples with a family history of genetic diseases

• Individuals of Ashkenazi Jewish, African, Mediterranean, or Southeast Asian descent (who have a higher prevalence of certain genetic disorders)

• Couples who are biologically related (e.g., cousins)

• Women over the age of 35, where the risk of chromosomal abnormalities is higher

• Individuals who have experienced multiple miscarriages or failed IVF cycles

What Happens If a Couple Are Found to Be Carriers?

If both partners are carriers of the same condition, they will be offered the option of:

• PGT-M during IVF to select embryos that are not affected

• Using donor sperm or eggs to avoid passing on the condition

• Prenatal testing during pregnancy (if they proceed without IVF)

Genetic counseling is a key part of the process, helping couples understand the risks, inheritance patterns, and their reproductive options.

Common Misunderstandings About Genetic Screening

“We have no family history, so we don’t need this.”

Actually, 80% of children born with genetic diseases have no family history of the condition. Many people are unaware they are carriers until testing is done.

“Genetic testing is like designer babies.”

Genetic screening is not about selecting traits like eye color or intelligence. It’s about preventing serious, sometimes fatal, diseases. It is strictly regulated and focused on medical necessity.

“It’s expensive and not worth it.”

While there is a cost, many clinics offer comprehensive carrier screening as part of their standard IVF package. In the long run, preventing a severe disease can save hundreds of thousands of dollars in medical care, not to mention the emotional toll.

Ethical Considerations

Genetic testing during IVF does raise ethical questions, particularly around embryo selection and discarding affected embryos. These are deeply personal decisions and should be made with careful guidance from physicians, genetic counselors, and, where needed, spiritual or ethical advisors.

It’s also important that testing is used responsibly, focusing on serious health conditions and avoiding misuse for non-medical trait selection.

A Real-Life Example

Consider a couple who both unknowingly carry a mutation for Tay-Sachs disease. Through IVF and PGT-M, they discover that two of their five embryos are affected. By transferring only unaffected embryos, they are able to have a healthy child. Without screening, their risk of a severely ill child—and a possible pregnancy termination—would have been 1 in 4.

The Future of IVF and Genetics

As technology advances, genetic screening will become even more precise, covering more conditions with higher accuracy. Whole-genome sequencing of embryos may one day be routine—but it will also demand stricter ethical oversight.

For now, genetic screening offers one of the most powerful tools in modern reproductive medicine: the ability to reduce suffering and give children the healthiest possible start in life.

IVF is a miracle of science, but it also gives us the opportunity—and responsibility—to make informed decisions about the future of our children. Genetic disease screening is not about control, but about care: protecting your future child from preventable illness, giving them the best chance to thrive, and ensuring your journey to parenthood is built on knowledge, choice, and peace of mind.

Whether you’re just starting your IVF journey or already deep into the process, consider speaking to your doctor about genetic screening. It could be one of the most important choices you make—not just for your pregnancy, but for your family’s future.